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Abstract The primary activation of the epidermal growth factor receptor (EGFR) has become a prominent 
target for molecular therapies against several forms of cancer. But despite considerable progress during 
the last years, many of its aspects remain poorly understood. Experiments on lateral spreading of receptor 
activity into ligand-free regions challenge the current standard models of EGFR activation. Here, we 
propose and study a theoretical model, which explains spreading into ligand-free regions without 
introducing any new, unknown kinetic parameters. The model exhibits bistability of activity, induced by a 
generic reaction mechanism, which consists of activation via dimerization and deactivation via a 
Michaelis-Menten reaction. It possesses slow propagating front solutions and faster initial transients. We 
analyze relevant experiments and find that they are in quantitative accordance with the fast initial modes 
of spreading, but not with the slow propagating front. We point out that lateral spreading of activity is 
linked to pathological levels of persistent receptor activity as observed in cancer cells and exemplify uses 
of this link for the design and quick evaluation of molecular therapies targeting primary activation of EGFR. 
Introduction
The ErbB family of receptor tyrosine kinases, consisting of the epidermal growth factor receptor 
(EGFR, also called HER1 or ErbB 1) and three other members (referred to as Her 2--4 or ErbB 
2--4), plays a prominent role in signaling pathways, which regulate important biological functions 
like proliferation, differentiation and cell survival. Dysfunctions and overexpression of these 
receptors are involved in carcogenesis. Since the seminal work of Kholodenko et al. [1] on the 
early stages of the EGF signaling cascade a number of increasingly refined and increasingly 
complex models of the ErbB signaling network have been published [2-4]. However, the very 
first stages of the cascade, especially the precise nature of transmembrane signaling after ligand 
binding remains poorly understood, despite the fact that it constitutes the most important target 
of molecular therapies in cancer cells overexpressing EGFR [5]. It is usually modeled as ligand-
induced dimerization of receptors, followed by the activation of the tyrosine kinase and trans-
phosphorylation of tyrosine residues on the C terminal. Unlike most other growth factor 
receptors, dimerization of EGFR is not achieved by crosslinking two receptor molecules with a 
bivalent ligand, and many experiments have revealed that primary EGFR activation is itself a 
highly complex and highly regulated process (see [6, 7]). The present body of experimental 
knowledge on structure and function of EGF receptors is not sufficient to offer a natural 
explanation for experiments, which demonstrate that EGFR phosphorylation can spread into 
EGF-free regions [8-10]. Verveer et al. [8] induced locally restricted activation of EGFR (fused 
with GFP) in the membrane of MCF7 cells by applying EGF covalently fixed to beads. Receptor 
phosphorylation was observed by measuring FRET between EGFR-GFP and a Cy3-labeled 
antibody to phosphotyrosine. They found lateral spreading of EGFR phosphorylation and they 
stressed the importance of secondary dimerization for this phenomenon. Sawano et al. [9] used 
a microfluidic device for local stimulation and report that the onset of lateral activity spreading 
depends on the concentration of EGF receptors in the plasma membrane. COS cells expressing 
EGF receptors at a normal density did not show spreading of activity. Reynolds et al. [10] 
studied a coupling of receptor kinase activity to an inhibition of protein tyrosine phosphatase via 
hydrogen peroxide (produced rapidly after EGFR stimulation) and already summarized their 
experimental findings in a schematic reaction scheme that implies bistable receptor activity.
All the experiments strongly suggest that there exists an autocatalytic property of EGF 
receptors (called “C” further on), which is switched on in a dimer consisting of active receptors 
and which turns these receptor molecules into activators of other ligand-free receptors. 
According to our present knowledge of the EGF receptor, this property is necessary for 
activation of receptors in EGF-free regions, although we should point out that it is lacking an 
explanation based upon structural features of the receptor molecule at present. We will show 
that property “C” can be implemented in a theoretical model without introducing any new, 
unknown parameters, if its kinetics is rigidly coupled to that of receptor phosphorylation. We will 
show that it provides quantitative explanations of key results of [8-10].
Activity spreading of EGFR emerges from a generic bistability of activity. This same 
bistability will lead to a pathologically high, permanent activity of genetically intact receptors, as it 
is observed in several types of cancer cells [11]. This link opens up new possibilities for the 
design and the evaluation of molecular therapies, which counteract the permanent receptor 
activity in cancer cells overexpressing EGFR. 
Results and Discussion
Model building for primary receptor activation
 Usually, EGF receptors are activated by ligand binding, but here, we concentrate on activity 
spreading in EGF-free regions; therefore we start from a reaction-diffusion (RD) model, which 
contains receptor monomers and dimers, but does not include ligands and ligand binding. Here, 
we concentrate on a single type of ErbB receptors (EGFR) for simplicity, the neccessary 
refinements to include ErbB 2--4 are straightforward and will be presented elsewhere. We take 
into account dimerization/dissociation and phosphorylation/dephosphorylation of receptors, and 
we rigidly couple the property “C” to phosphorylation, i.e. every genetically intact receptor is 
assumed to have property “C” switched on, if its C-terminal sites are phosphorylated and
switched off if they are not phosphorylated. In the absence of any information on the kinetics of 
property “C”, this is the simplest hypothesis, which does not contradict the body of experimental 
observations. As we are not interested in downstream signaling, we do not discriminate between 
different phosphorylation sites. Specific rate constants are introduced for dimerization (D), for 
dissociation (-D) and for phosphorylation (P), with default values
1 1 1= 0.01 = 0.01 = 0.031D D Pk nM s , k s , k s
   
 , respectively. Dephosphorylation (-P) is modeled 
by a Michaelis-Menten kinetics with values for 1=0.5maxv nMs
  and for =30K nM  taken from 
recent in vivo experiments by Yudushkin et al. [12]. The kinetics is assumed to be independent 
of dimerization. Therefore, the Michaelis-Menten rate law /P max ak = v (K +n )  depends upon the 
total density of active receptors, an . Additional phosphatase inhibition can be taken into account 
by smaller values of K  at fixed /maxv K . All the default values of the rate law parameters have 
been taken from independent standard models and experiments [1, 12-14], (see supporting text 
S1 for details). RD equations are set up for the densities 1n , 0n  of active and inactive monomers 
and 00m , 10m  and 11m  of dimers containing zero, one or two active receptors. These densities 
change by diffusion (diffusion constant 2 11=0.1D μm s   for monomers and 2 1 / 2D = D  for 
dimers) and by reactions with velocities, which are collected in Tab.1. Note that we have added 
rates 1Pb  and 2Pb , which correspond to spontaneous phosphorylation of monomers or dimers, 
respectively, and which lead to a basal level of activity, which we adapted to specific cell types. 
For some numerical experiments, we also use spatiotemporal profiles of these rates as a 
substitute for ligands to drive receptor activation. The crucial autocatalytic reaction steps of 
property “C” are depicted in Fig. 1. Ultimately, EGFR activity is downregulated via receptor 
internalization, which we do not take into account here, as our main results will be of relevance 
for timescales of up to 5 minutes. 
Using the operators 2a t aR = D   , with =1a  for monomers and =2a  for dimers, the complete 
set of RD equations of our model takes on the compact form 1
D Pn v v   R  and 
2
D Pm w w      R  with  , 0,1  . The system is discussed in detail in the supporting text S1. 
In the absence of diffusion, the five rate equations of our model lead to bistable
behaviour of the receptor activity within a wide range of parameters. This bistability constitutes 
the basis of spatial spreading of activity. We have numerically solved the model consisting of 5 
RD equations using standard finite element methods, but to gain more insight into underlying 
mechanisms, additional analytical discussions are helpful. First, it is convenient to use a different 
set of variables. Instead of 0 1 00 10 11n ,n ,m ,m ,m , we introduce the density of monomers 0 1n = n +n , 
the density of dimers 11 10 11m = m +m +m , and the total density of active receptors 
1 10 112man = n +m +  together with 1n  and 10m  to describe the state of the system. The density 
an  is proportional to (ratiometrically calibrated) FRET signals of the experiments [8, 9, 10], 
which probe the phosphorylation of tyrosine residues of EGFR. Thus an  will be the quantity of 
central interest in the following. The spatial averages of densities 1n  and an  have to obey the 
inequalities 1n n  and 1 10an c n+ n m    to ensure positive 0n  and 00m . c , the spatial 
average of receptor concentration is also used to define the dimensionless fraction of active 
receptors,  /A an = n c .
After expressing the RD equations in the new set of variables, two simplifications 
become obvious, which help to understand the dynamics of the system. First, the equations for 
n  and m  decouple from the rest of the system and take on the simple form (note that 2mn+  is 
the total receptor density) 
2 2 2
1 22 .t t D D( D )n = ( D )m = k m k n       
 The dimer/monomer equilibrium is not disturbed by changes in receptor activity, 
therefore we can use the stationary values  * 1 4k / 1 / 2kD D D Dn = k + c k ( )    and
* * /2m = ( c n ) . This simplification is due to our assumption of state-independent dimerization 
and dissociation rate constants. Second, the system can be approximated by a single equation 
for an , and this approximation, which is based on separation of timescales and lengthscales 
(relaxation of an  is much slower than that of the other densities), keeps the key aspects of the 
full dynamics. We introduce it here because we will make use of its explanatory power. Details of 
the model reduction can be found in the supporting text S1. The resulting RD equation for an
takes on the form 
2 * 2 *
2 1 1 1t a a a a an = f(n )+ D (n n (n ))+ D n (n ),   
 where *1n  is obtained by putting 
2 *
1 1 0t( D )n    . The 2 diffusion terms correspond to 
the subpopulations of active dimers and active monomers contained in an .
The dependence of activity spreading on receptor density is correctly predicted 
by the model
Fig. 2 displays af(n )  for =100c nM  and =200c nM  and clearly exhibits a bistability of 
an  for an intermediate range of receptor densities and default values of kinetic parameters. In 
the bistable regime the system may be driven from a state of low, basal activity to a highly active 
state by the application of a stimulus, which can be localized in space and time as will be 
discussed in the next subsection. Indeed, a density dependence of spreading was observed in 
[9]. Therefore, as shown in Fig. 3, we have compared the density dependence of stationary and 
homogeneous activities resulting from our model to those of studied cell lines. According to our 
model, native COS cells ( 20c nM ) should not exhibit bistable behaviour and activity 
spreading, whereas COS cells overexpressing EGF receptors and MCF7 cells ( 300c nM ) 
should. This is in accordance with the results of [8-10]. A431 cells ( 600c nM ) should be 
constitutively active at pathologically high levels (even without permanently active mutants). 
Here, we have considered levels of basal activity of 3% - 5%. The lower the basal activity, the 
more the bistable regime extends towards higher densities.
Activity spreading is based on a new generic bistable reaction scheme
The reaction mechanism underlying this bistability is a robust and generic one, and is 
composed of an interplay of two steps, which are frequently met in biochemical reactions of the 
cell, namely, a deactivation via an enzymatic reaction, which is counteracted by an activation via 
dimerization. Fig. 4 shows a rate balance plot based upon a decomposition of the rate law of 
active receptors, 
a + a a P a af(n )= r (n )n k (n )n
into an effective creation rate  * * * *10 1P 1 2P 00 /+ a P a a a ar (n )= k m (n )+b (n n (n ))+b m (n ) n  and a 
destruction rate, which is just P ak (n ) , as expected. The structure of +r  is also quite 
comprehensible: additional active receptors arise from auto-phosphorylation in dimers and from 
the spontaneous phosphorylation events in inactive monomers and inactive dimers. Note that for 
1P 2P =0b = b  there will be no receptor activation without dimerisation. The solid line in Fig. 4 has 
the well-known hyperbolic form of Michaelis-Menten kinetics. If it was combined with a creation 
rate, which increases with an , it would always lead to a single equilibrium point. The rate +r , 
however, decreases with an  and gives rise to an extended region of bistability in parameter 
space. The steep decrease of +r  for small an  is entirely due to spontaneous phosphorylation. 
The dash dotted curve corresponds to +r  at 1P 2P =0b = b  and is very close to a straight line, the 
hallmark of dimerization rates. Note that in this case =0an  is always a fixpoint although it is not 
visible in the rate balance plot. We cannot extend the rates to =1An , because values of An
beyond 0.93  are not admissible in the reduced model as they violate the condition of positivity of 
00m  discussed above. 
Experimental results on spreading of activity are explained quantitatively
 Let us now compare our model to the quantitative experimental results on spreading of activity 
in [8-10]. A suggestive first explanation of the observed spreading might identify it with a 
propagating front solution of the model. Standard analysis and numerical solution reveal that the 
full and the reduced model possess propagating plane front solutions of the form 
an (x, y,t)= f(x vt)  on an extended rectangular membrane located in the (x y)  plane [15]. The 
fronts propagate in positive x direction if receptors are kept active at the left boundary of the 
rectangle. The profile of the front is a sigmoidal function joining a high value a,ln  at the left 
boundary to a low value a,rn  at the right boundary and we may define a width of this profile by 
:= /a,l a,rw (n n ) | s | , where s  is the slope of f  at its inflection point. We solved the full and the 
reduced model numerically on a long rectangular strip and studied the front connecting the two 
stable homogeneous fixpoints of our model for default kinetic parameters and =200c nM . We 
found a velocity of =0.014 1v μms  and a width of =25.75w μm . At first sight, these values seem 
to rule out that the observed spreading of activity is explainable by the asymptotic motion of the 
front solution, because the velocity is much slower than the observed spreading and the width of 
the front is comparable to the cell size.
Nevertheless, the model is in accordance with experimental findings, if we perform a 
more detailed comparison, including the initial, transient dynamics of a stimulated system, which 
can be much faster than the asymptotic propagating front. Let us first consider the experimental 
setups of [8] and [10], which use beads with covalently fixed EGF to stimulate the system. 
Interactions between ligand bound receptors and inactive receptors can only take place at the 
boundary of the stimulated regions. The beads are mapped to our model as circles (of 0.8 μm  in 
diameter) with fixed boundary conditions of high receptor activity. In [8] cells on coverslips were 
drained and overlaid with a suspension containing 54 10  beads per microliter, which leads to a 
fluctuating number of beads fixed to the plasma membrane. From data of [8] and [10], we found 
3 20  beads randomly distributed on the cell surface. Receptor activity is observed to spread 
over the surface on a timescale of at least 1 2  minutes. The average distance between beads 
depends upon the geometry of the cell attached to substrate. If we take a roughly cylindrical 
geometry of a cell with 21000 μm  surface, there is 2500 700 μm  of available membrane 
surface for stimulation, so that beads control areas of 2.8 8.6 μm  radius. From the boundary of 
beads activity has to spread 2.5 8 μm  before the activated regions start to overlap. Given the 
fluctuating number of beads we decided to study the activity spreading emerging from a single 
bead by following the temporal development of levels of fixed activity /an (r,t) c = const  (activity 
isoclines) from a single bead. Fig. 5 reveals that initially levels of activity up to 0.4 0.5  spread 
several times faster than the asymptotic front and may overlap within 1--2 minutes. As soon as 
levels overlap, their development is accelerated further as shown in Fig. 6, which displays 
activity isoclines after 20, 40 and 60 seconds. On the other hand, high levels of activity spread 
significantly slower than the asymptotic front, so that receptor internalization sets in before these 
levels start to overlap.
Now we turn to [9], where ligand is applied in a microfluidic flow channel. This provides a 
ligand profile with sharp boundary, but in contrast to [8] and [10], ligand-bound EGFR molecules 
are free to diffuse. As the EGF unbinding rate is small, 10.004 s  , a receptor can diffuse for 
250 s  before it looses its EGF ligand. It is important to include this smearing out effect of initial 
activity to achieve a satisfactory agreement between the model and experimental data. Fig. 7 
compares numerical results from our model with Fig. 6 of [9], which shows the spreading of 
phosphorylation for transfected COS cells. We monitor the time course of activation an  at 
=0x μm , =10x μm , =20x μm , and =30x μm , which corresponds to the regions of interest 
marked in Fig 6. of [9].
The experimental setups may also be used to test an important prediction of the model, 
the appearance of critical pulses. For each spatial profile of activation the model predicts a 
critical minimal activation time necessary to induce activity spreading. For strip-like stimulation 
profiles as they are available in microfluidic devices, we have calculated that critical pulse 
duration is between 10 s  to 15 s  (see supporting text S2 for more details), if 10% of the
receptors are stimulated. 
The model provides hints for targeted molecular therapies 
 In cancer cells, which overexpress EGFR, tyrosine kinase inhibitors like gefitinib (Iressa TM ) and 
erlotinib (Tarceva TM ), and monoclonal antibodies against the EGFR ectodomain, like cetuximab 
(Erbitux TM , for ErbB1), trastuzumab (Herceptin TM , for ErbB2) have shown to suppress tumor 
growth with some success [16, 17]. Recently, the EGFR related protein (ERPP) has been shown 
to effectively inhibit several ErbB receptors including ErB1 and ErbB2, presumably by ligand 
binding and sequestration and by the formation of inactive heterodimers with ErbB receptors
[18]. The inherent bistability of receptor activity discussed above provides a quantitative link 
between the phenomenon of activity spreading and the appearance of pathologically high levels 
of intact, persistently active receptors. The proposed model of primary activation helps in the 
design and quick evaluation of molecular therapies with targets, which directly influence 
parameters of the model.
To illustrate this point, we consider the control of phosphorylation rate Pk , a model 
parameter susceptible to kinase inhibitors, and of the total density of receptors c , which in effect 
may be reduced by monoclonal antibodies, if they completely inactivate receptors. In Fig. 8, the 
stability regions in the T Pc k  plane are shown, other model parameters are kept to their default 
values. It illustrates the scenario of a combined therapy, which will lead back to normal basal 
activity level, although this cannot be achieved by separately applying a kinase inhibitor or an 
antibody, which inactivates receptors.
 Fig. 9 displays the onset of pathological activity levels due to genetic defects, which 
increase 1Pb  (as a first, oversimplified means to include effects of constitutively active 7Δ2 
mutants) and overexpress EGFR. Note that attempts to reconstitute a stable low level of activity 
by reducing the spontaneous activation of monomers will only succeed in the small shaded 
region of Fig. 9, if it is not accompanied by a reduction of expression level. We have also studied 
other potential targets to inhibit EGFR activity and found that stabilizing dimers by reducing the 
dissociation rate Dk  may also be a promising means to reestablish a normal activity level (see 
supporting figure S3 for more details). These simplified examples can easily be extended to 
more realistic settings, but they already show the potential for additional, quantitative methods of 
investigation in the field of EGFR targeted molecular therapies.
In summary, we have set up a new computational model of spatially resolved activation of 
EGFR, which explains experimental findings of lateral activity spreading. Our basic hypothesis, 
i.e. an autocatalytic activation kinetically linked to phosphorylation, proved to be in quantitative 
accordance with existing experiments so far, without introducing any new and unknown kinetic 
parameters. The activity spreading turned out to be based on a generic bistability, which will 
show up, whenever Michaelis Menten kinetics is counteracted by dimerization or other types of 
reactions possessing rates, which decrease with concentration of the product. Using kinetic 
constants from the established models we find that the bistability only occurs within an 
intermediate range of receptor densities. Our model correctly predicts, which of the 
experimentally used cell lines show activity spreading and which show homogeneous, low or 
high basal activity. The model allows to calculate the evolution of activity patterns following a 
stimulating pulse of any shape, strength and duration and thereby provides a wealth of 
experimentally testable predictions. We have shown in detail how to compare it to experimental 
findings.
It is an interesting feature of the model that it contains a quantitative link between the 
pathologically high activity levels in cancer cells overexpressing EGFR and the phenomenon of 
activity spreading. We have presented some oversimplified examples to demonstrate the 
usability of this link in the design of molecular therapies and to show that it can open up a new 
and promising field of quantitative research for molecular therapies.
Although our results indicate that bistability and activity spreading only occur in cell lines 
overexpressing EGFR, it may still be possible that the signal amplification due to activity 
spreading is a useful physiological mechanism. EGF receptors are known to cluster and can 
form patches of higher density, where activity spreading becomes possible. If spreading activity 
pulses are rare events and the cell can downregulate the receptor activity (via internalization of 
receptors), bistability constitutes a useful intrinsic discriminator between less important (sub-
threshold) signals and important ones.
Methods
 The model of primary EGFR activation discussed above was formulated as 5 RD 
equations on bounded two-dimensional regions, either rectangluar or circular, with von 
Neumann boundary conditions. The model equations together with reformulations and 
reductions are discussed in detail in the supporting text S1. The system of parabolic partial 
differential equations was solved numerically by triangulating the reaction regions and using a 
standard, freely available finite element library [19] to solve the boundary value problems. The 
mesh size was chosen such that every cell constitutes a well-stirred reaction volume. The time 
evolution was constructed by discretising time and applying a simple Rosenbrock method [20]. 
Numerical errors were checked by changing discretisation parameters (time intervals and mesh 
sizes). The system was driven either by boundary conditions on additional interior boundaries 
representing localized ligand or by spatiotemporal profiles of spontaneous phosphorylation rates 
to model ligand pulses in microfluidic devices. 
Supporting material
Supporting material is available from 
http://www.theorie.physik.uni-goettingen.de/~jentsch/supp.pdf
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Figure 1: EGFR activation. Left part: The standard ligand induced activation of EGFR. Ligand 
(black circle) binds to 2 receptor monomers with inactive kinase (white ellipse), which 
subsequently dimerize and thereby activate their kinases (black ellipse). All reaction steps 
(undirected lines) are reversible. Right part: Activation of EGFR with property C. An active 
monomer may bind to an inactive one. The resulting dimer can either switch to an inactive state 
(irreversibly, as indicated by the directed line), thereby enhancing the population of inactive 
receptors or the active receptor can (via property C) activate the other receptor. After 
dissociation, this enhances the population of active monomers with property C
Figure 2: Bistability of EGFR activity. Reaction velocity of active receptors af(n )  vs. the 
fraction of active receptors /A an = n c  for average receptor densities of =200c nM  (upper curve) 
and 100nM  (lower curve) and for default kinetic parameters. Zeroes of f  correspond to 
homogeneous, stationary states. Spatially homogeneous initial conditions with An  beyond the 
threshold (2) are driven to the fixpoint with high activity. 
Figure 3: Dependence of fixpoints on total receptor concentration. Fixpoints of An  vs. 
average receptor concentration Tc = c . The vertical lines a), b) and c) correspond to 
concentrations of normals COS cells (a), transfected COS cells overexpressing EGFR as used 
in Ref. [9] (MCF7 cells as used in Ref. [8]  have comparable densities) and (c) corresponds to 
A431 cells. We estimate the densities for a cell with a radius of 10μm , where =100Tc nM
corresponds to 52.4 10  receptors. 
Figure 4:  Rate balance plot. Solid line: Michaelis-Menten rate law of dephosphorylation. 
Dotted line: effective activation rate +r , which contains spontaneous phosphorylation 
(dominating for 0an  ) and a rate limiting dimerization step. Dash-dotted line: +r  without 
spontaneous phosphorylation. The reduced model correctly reproduces the equilibrium states 
per definition, but looses its applicability in the gray shaded area, where it violates the positivity 
of 10m .  
Figure 5: Activity spreading from focal stimulation. Activity isoclines of a single bead are 
circles of radius r(t)  increasing with time. An average (radial) velocity up to time T  is defined as 
0 /v(T)= (r(T) r( )) T . The figure shows 60v( sec) and 300v( sec)  in units of the front velocity 
=0.014 1frontv μms  vs. the activity level. Lower activity levels start out with a considerably higher 
velocity and slow down, but the velocities of higher activity levels may fall well below frontv . 
Figure 6: Activity spreading from focal stimulation with two beads. The =0.1an  isoclines of 
two beads (shaded circles) are shown for =20,40T  and 60  seconds. Note that the separation 
between the isoclines first decreases, but increases again when the activated regions from both 
beads start to overlap.  
Figure 7: Modelling microfluidic stimulation. To compare with experimental results from Ref. 
[9] we solve the RD equations on a 30 20μm  membrane with a strip-like, sigmoidal activation 
1P 1Ptanh /b (x)= b (x ξ)  with =13ξ μm . In a homogeneous stimulation, 1Pb  will lead to a stationary 
activation of 0.93an  . The curves correspond to different distances from the left boundary 
( =0,10,20,30x μm ), chosen in accordance with the regions of interest monitored in [9]. The 
experimental results consist of normalized FRET signals and are shown in the inset. See [9] for 
further details.
Figure 8: Phase diagram in the P Tk c plane. The solid lines divide the P Tk c  plane into 
states of pathologically high basal activity (upper part), bistable activity (as marked, considered 
still as pathological activity here) and states of normal basal activity (lower part) (phase 
diagram). Therapies, which reduce the expression level ( Tc ) of receptors or inhibit kinase 
activity by certain values, may not be completely successful (as indicated by arrows). When both 
therapies have failed, a combination of the two therapies may lead back to normal basal activity. 
Figure 9: Phase diagram in the 1P Tb c  plane. An increase of spontaneously active receptors 
may be due to a genetic defect. Note that there is only a very small regime of Tc  expression 
levels (gray shaded), where reducing the level of genetically defect receptors is an efficient 
therapy.  
Table 1:   Reaction velocities
velocity decrease increase
0
Dv 20 0 1D Dk n k n n   00 102Dk m m 
0
Pv 1 0Pb n   1P ak n n
1
Dv 21 0 1D Dk n k n n   11 102Dk m m 
1
Pv 1( )P ak n n 1 0Pb n
00
Dw 00Dk m 20 / 2Dk n
00
Pw 2 002 Pb m 10( )P ank m
10
Dw 10Dk m 0 1Dk n n
10
Pw 10 10( )P P ak m k n m  11 2 002 ( ) 2P a Pk n m b m 
11
Dw 11Dk m 21 / 2Dk n
11
Pw 112 ( )P ak n m 10Pk m
Reaction velocities of monomers are denoted by v (those of dimers by w). The lower index refers 
to the subpopulations (0=inactive, 1=active) and the upper index characterizes the reaction 
(P=(de)-phosphorylation, D=dimerisation/dissociation). The velocities are decomposed into 
parts, which increase or decrease the corresponding subpopulation.









